Taken together, these results demonstrate that BUB1B is overexpressed in HCC in vivo and in vitro, suggesting that BUB1B is probably involved in the tumorigenesis and progression of HCC and a likely prognostic biomarker for HCC. Here, BUB1B is linked to hepatocellular carcinoma.